Cushing's syndrome: update of diagnosis and management.
Although considerable advances have been made in the understanding of Cushing's syndrome in the recent past, many difficulties persist in the diagnosis and management of patients with hypercortisolism. Precision in the diagnosis of Cushing's syndrome and the differentiation of its various forms have gradually improved, but a substantial number of cases have laboratory or radiologic findings that can be misleading or at least difficult to interpret. Furthermore, other conditions may mimic Cushing's syndrome and add to the diagnostic difficulties. Surgical extirpation of primary adrenal lesions that cause the hypercortisolism or of the neoplasms responsible for the ectopic production of adrenocorticotropic hormone remains the treatment of choice for these problems. Currently, transsphenoidal surgical exploration is the treatment of choice for Cushing's disease.
D000236:Adenoma / Q000150:complications; D000311:Adrenal Glands / Q000000981:diagnostic imaging; D000324:Adrenocorticotropic Hormone / Q000096:biosynthesis; D000328:Adult; D003346:Corticotropin-Releasing Hormone; D003480:Cushing Syndrome / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000601:surgery; D003864:Depression, Chemical; D003907:Dexamethasone; D003937:Diagnosis, Differential; D006801:Humans; D006854:Hydrocortisone / Q000096:biosynthesis; D007016:Hypophysectomy; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D010673:Pheochromocytoma / Q000175:diagnosis; D010911:Pituitary Neoplasms / Q000150:complications; D012008:Recurrence; D014057:Tomography, X-Ray Computed
D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone; D008797:Metyrapone